Phathom PharmaceuticalsPHAT

那斯達克 · USD
8.48
+0.03
(+0.36%)
盤中 08/06 12:14 (UTC+8)
08/06 12:14 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • 0.02
  • 0.07
  • 0.16
  • 0.30
  • 0.29
  • 0.40
  • 0.50
  • 0.58
  • 0.58
  • 0.74
icon
  • 180.35
  • 283.05
  • 123.27
  • 81.41
  • -3.86
  • 38.52
  • 25.31
  • 16.32
  • 1.25
  • 27.40
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2026/Q2
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
營業收入淨額
74,274
58,301
57,584
49,503
39,504
28,519
29,664
16,352
7,324
1,912
營業成本
15,09511,9967,6486,1895,0383,7243,8152,3561,376426
營業毛利
59,179
46,305
49,936
43,314
34,466
24,795
25,849
13,996
5,948
1,486
營業費用
63,14461,78255,86458,58694,389103,658---71,440
研發費用
7,8147,7717,4937,0279,0769,1848,5838,6937,3769,430
推銷及管理費用
55,33054,01148,37151,55985,31394,47476,68376,09975,87262,010
非經常性項目費用
----------
其他營業費用
----------
營業利益
-3,965
-15,477
-5,928
-15,272
-59,923
-78,863
-59,417
-70,796
-77,300
-69,954
其他收入及費用
1,4869051,1991,4071,6302,6183,5593,7033,6184,270
利息費用
15,10315,79716,41916,10817,51718,07118,59318,48417,76417,168
稅前純益
-17,582
-30,369
-21,148
-29,973
-75,810
-94,316
-74,451
-85,577
-91,446
-82,852
所得稅
----------
稅後純益
-17,582
-30,369
-21,148
-29,973
-75,810
-94,316
-74,451
-85,577
-91,446
-82,852
基本每股稅後盈餘(元)
-0.21-0.37-0.29-0.41-1.05-1.31-1.05-1.32-1.56-1.42
稀釋每股稅後盈餘(元)
-0.21-0.37-0.27-0.41-1.05-1.31-1.00-1.31-1.56-1.42
基本平均股數(千股)
83747.0082050.0073817.0073396.0072466.0071969.0071044.0064627.0058558.0058371.00
稀釋平均股數(千股)
83747.0082050.0073817.0073396.0072466.0071969.0071044.0064627.0058558.0058371.00
還原基本每股稅後盈餘(元)
-0.21-0.37-0.29-0.41-1.05-1.31-1.05-1.32-1.56-1.42
還原稀釋每股稅後盈餘(元)
-0.21-0.37-0.27-0.41-1.05-1.31-1.00-1.31-1.56-1.42
還原基本平均股數(千股)
83,74782,05073,81773,39672,46671,96971,04464,62758,55858,371
還原稀釋平均股數(千股)
83,74782,05073,81773,39672,46671,96971,04464,62758,55858,371
EBITDA(千元)
-1,453-13,618-3,792-12,934-57,387-75,372-55,036-66,313-72,985-64,996

大家都在看

HOT